Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CMS Denial of Astellas’ Cresemba Add-On Payment Could Boost Legislative Solution

This article was originally published in The Pink Sheet Daily

Executive Summary

Bad news might be good news in the long term if Astellas’ woes highlight need for special antimicrobial reimbursement, which is one provision of the 21st Century Cures Act.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register